301 related articles for article (PubMed ID: 16332438)
1. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
2. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.
Halder AK; Adhikary N; Maity MK; Jha T
Eur J Med Chem; 2010 May; 45(5):1760-71. PubMed ID: 20133022
[TBL] [Abstract][Full Text] [Related]
4. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones.
Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF
Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
7. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells.
Manojkumar P; Ravi TK; Subbuchettiar G
Acta Pharm; 2009 Jun; 59(2):159-70. PubMed ID: 19564141
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of 3-formylchromones and related compounds.
Kawase M; Tanaka T; Kan H; Tani S; Nakashima H; Sakagami H
In Vivo; 2007; 21(5):829-34. PubMed ID: 18019419
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent.
Tumiatti V; Milelli A; Minarini A; Micco M; Gasperi Campani A; Roncuzzi L; Baiocchi D; Marinello J; Capranico G; Zini M; Stefanelli C; Melchiorre C
J Med Chem; 2009 Dec; 52(23):7873-7. PubMed ID: 19954251
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells.
Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM
Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322
[TBL] [Abstract][Full Text] [Related]
13. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
14. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Ghorab MM; Noaman E
Eur J Med Chem; 2010 May; 45(5):1849-53. PubMed ID: 20149941
[TBL] [Abstract][Full Text] [Related]
15. Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Samanta S; Alam SM; Panda P; Jha T
Eur J Med Chem; 2009 Jan; 44(1):70-82. PubMed ID: 18456372
[TBL] [Abstract][Full Text] [Related]
16. Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
Cho WJ; Le QM; My Van HT; Youl Lee K; Kang BY; Lee ES; Lee SK; Kwon Y
Bioorg Med Chem Lett; 2007 Jul; 17(13):3531-4. PubMed ID: 17498951
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of chromone-based p38 MAP kinase inhibitors.
Dyrager C; Möllers LN; Kjäll LK; Alao JP; Dinér P; Wallner FK; Sunnerhagen P; Grøtli M
J Med Chem; 2011 Oct; 54(20):7427-31. PubMed ID: 21905739
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
